Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ronald Couri"'
Publikováno v:
Cancer Research. 83:P5-07
INTRODUCTION: Much progress has been made related to fertility preservation in women diagnosed with breast cancer. This includes heightened awareness of impaired fertility due to breast cancer treatment, increased referrals to fertility specialists a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::935f75e5fbe06214a3bb8c68551e4ffe
https://doi.org/10.1158/1538-7445.sabcs22-p5-07-02
https://doi.org/10.1158/1538-7445.sabcs22-p5-07-02
Autor:
Shkala, Karzai, Elisa, Port, Cleo, Siderides, Christopher, Valente, Soojin, Ahn, Erin, Moshier, Meng, Ru, Kereeti, Pisapati, Ronald, Couri, Laurie, Margolies, Hank, Schmidt, Sarah, Cate
Publikováno v:
Annals of Surgical Oncology. 29:4116-4124
There is little data exploring the impact of screening mammography on subsequent treatment in the 40-49-year age group with breast cancer. We sought to assess the association between frequency of mammography in young women and extent of surgery and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c09e2fa5f8e07d62a54dbc544dbda8a2
https://doi.org/10.1245/s10434-022-11581-6
https://doi.org/10.1245/s10434-022-11581-6
Autor:
Shkala Karzai, Elisa Port, Cleo Siderides, Christopher Valente, Soojin Ahn, Erin Moshier, Meng Ru, Kereeti Pisapati, Ronald Couri, Laurie Margolies, Hank Schmidt, Sarah Cate
Publikováno v:
Annals of Surgical Oncology. 29:4125-4126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74d6c10beb7c7833c3b3ac6798011ff3
https://doi.org/10.1245/s10434-022-11636-8
https://doi.org/10.1245/s10434-022-11636-8
Autor:
Elisa Port, Christopher Valente, Ru Meng, Kereeti Pisapati, Soojin Ahn, Margaux Wooster, Laurie R. Margolies, Hank Schmidt, Erin Moshier, Ronald Couri
Publikováno v:
Annals of Surgical Oncology. 25:2979-2986
Screening mammography reduces breast cancer mortality; however, screening recommendations, ordering, and compliance remain suboptimal and controversies regarding the value of screening persist. We evaluated the influence of screening mammography on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a3a8e697cd7534f7a200497cb2e007a
https://doi.org/10.1245/s10434-018-6646-8
https://doi.org/10.1245/s10434-018-6646-8
Autor:
Hanane Arib, Natalie Berger, Kereeti Pisapati, Hanna Y. Irie, Elisa Port, Olivia Kolodka, Alan Soto, Robert Sebra, Paul H. Schmidt, Yayoi Kinoshita, P Klein, Michael J. Donovan, Ronald Couri
Publikováno v:
Cancer Research. 80:P5-01
Background/Rationale: Sensitivity to chemotherapy consistently remains a strong predictor of long term outcomes and survival for patients diagnosed with triple negative breast cancer (TNBC). Patients who do not achieve a complete pathological respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7ec4c4859bb85a76ab293742d3bac4c
https://doi.org/10.1158/1538-7445.sabcs19-p5-01-09
https://doi.org/10.1158/1538-7445.sabcs19-p5-01-09
Autor:
Michael J. Donovan, Robert Sebra, Paul H. Schmidt, Hanna Irie, Kereeti V. Pisapati, Alan Soto, Yayoi Kinoshita, Elisa R. Port, Ronald Couri, Olivia Kolodka, Hanane Arib
Publikováno v:
Journal of Clinical Oncology. 36:e24108-e24108
e24108Background: Patients with early stage triple negative breast cancer (TNBC) are treated with multimodality therapy (chemotherapy, surgery, radiation). Cell-free DNA (cfDNA) and circulating tum...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd56ea716021b62485af1e6eaf94eac6
https://doi.org/10.1200/jco.2018.36.15_suppl.e24108
https://doi.org/10.1200/jco.2018.36.15_suppl.e24108
Autor:
Elisa R. Port, Hanna Irie, Robert Sebra, Janis De La Iglesia, Kereeti V. Pisapati, Paul H. Schmidt, Ronald Couri, Olivia Kolodka, Hanane Arib, Michael J. Donovan, Yayoi Kinoshita
Publikováno v:
Journal of Clinical Oncology. 35:e23070-e23070
e23070 Background: Serial liquid biopsy assessment provides a unique platform for detecting existing and / or emergent resistance mutations; it may be particularly beneficial when patients begin to progress on otherwise effective therapy. We aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::559d2d63b30519526d2b04a696669aa0
https://doi.org/10.1200/jco.2017.35.15_suppl.e23070
https://doi.org/10.1200/jco.2017.35.15_suppl.e23070